Faculty Information - HORIUCHI Kiyomi

■ Published papers

1.	Original article	Discordance of intrinsic subtype between primary tumor and lymph node metastasis in breast cancer patients 2026
2.	Original article	Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach 2025/07/03
3.	Original article	Predicting Tumor Volume in Primary Hyperparathyroidism From Preoperative Clinical Data 2025/01/21
4.	Original article	Outcomes of Patients with an Intermediate-Risk Group According to the Japanese Risk Classification of Papillary Thyroid Carcinoma 2023/06
5.	Original article	Predictive value of metastatic lateral lymph node ratio for recurrence in pathologically lateral lymph node-positive papillary thyroid cancer patients with palpable lymph nodes 2022/07
6.	Original article	Fatigue and quality of life among thyroid cancer survivors without persistent or recurrent disease 2022/03/16
7.	Case report	A case of tertiary hyperparathyroidism due to hypophosphatemic rickets 2022/02/25
8.	Case report	Papillary thyroid microcarcinoma with multiple pulmonary metastases following lung cancer surgery: a case report 2022
9.	Review article	Radioactive iodine treatment of papillary thyroid carcinoma in Japan 2020/05
10.	Original article	Low‑dose radioiodine therapy for patients with intermediate‑ to high‑risk differentiated thyroid cancer 2019/12/13
11.	Review article	International comparison of papillary thyroid carcinoma treatment according to clinical guidelines -　Postoperative adjuvant therapy - 2019
12.	Original article	Impact of Tailored parathyroidectomy for treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1 2018
13.	Original article	Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up 2018
14.	Case report	Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case. 2017/12
15.	Original article	safety and tolerability of vandetanib in japanese patients with medullary thyroid cancer: a phase I/II open-label study 2017/02
16.	Original article	An analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution 2013
17.	Original article	clinical features of insulinoma in patients with multiple endocrine neoplasia type1: analysis of the database pf the MEN consortium pf Japan 2012/06
18.	Original article	delay in the diagnosis of multiple endocrine neoplasia type 1: typical symptms are frequently overlooked 2012/02
19.	Original article	multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database 2012
20.	Original article	Usefulness and indication of 99m Tc-methoxyisobutylisonitrile(MIBI) for preoperative localization in patients with primary hyperparathyroidism 1997
Display 5 items
Display all(20)

■ Academic conference presentation

1.	A case of decreased urinary metanephrines resulting from reduced serum catecholamines in a patient with multiple endocrine neoplasia type 2B treated with selpercatinib （Poster notice，General） 2025/04/03
2.	Practical guideline and changes for diagnosis and treatment of adrenal incidentaloma （Speech，Panelist at Symposium/Workshop (Appointed)） 2025/04/03
3.	HOW WILL NEWLY DEVELOPING TARGETED THERAPIES CHANGE THE SEQUENCE OF THYROID CANCER MANAGEMENT? AN ENDOCRINE SURGEON’S PERSPECTIVE （Speech，Panelist at Symposium/Workshop (Appointed)） 2024/08/29
4.	Reevaluating surgical indications for asymptomatic primary hyperparathyroidism: hypercalciuria is not a urinary stone risk （Poster notice，General） 2024/08/27
5.	The frequency of postoperative hypoglycemia after pheochromocytoma surgery is decreasing （Speech，General） 2024/08/27
6.	The postoperative clinical course of pheochromocytoma in patients with multiple endocrine neoplasia type2 (MEN2) （Poster notice，General） 2024/08/27
7.	Surgery for primary hyperparathyroidism in MEN1 （Speech，General） 2023/03/17
8.	Impact of urinary calcium excretion on urinary stones primary hyperparathyroidism （Poster notice，General） 2023/03/16
9.	Predicting tumor volume in primary hyperparathyroidism from preoperative clinical data （Poster notice，General） 2023/03/16
10.	Quality of life in patients with primary hyperparathyroidism without surgery （Speech，General） 2023/03/16
11.	Lateral neck dissection （Speech，Panelist at Symposium/Workshop (Appointed)） 2020/03/07
12.	Treatment outcomes of papillary thyroid carcinoma following the Japanese guidelines for the management of thyroid tumors 2020 （Poster notice，General） 2019/10/31
13.	Mulifocal papillary thyroid carcinoma : is completion thyroidectomy necessary to improve the prognosis? （Poster notice，General） 2019/08/11
14.	Report of MEN1 Registry of Japan. 2018/03/08
15.	Prognosis and prognostic factors for cancer mortality in patients with lymph node metastases from papillary thyroid carcinoma as a first-time recurrence （Poster notice，General） 2017/10/19
16.	Prediction of malignancy in thyroid nodules with macrocalcification by ultrasonography （Poster notice，General） 2017/09/09
17.	Impact of risk classification of papillary thyroid carcinoma based on the Japanese clinical guideline and prognostic factors in gray zone （Poster notice，General） 2017/08/14
18.	CLINICOPATHOLOGICAL CHARACTERISTICS OF FALSE NEGATIVE CASES IN FDG-PET/CT SCAN PERFORMED AS PREOPERATIVE AXILLARY ASSESSMENT FOR INVASIVE BREAST CANCER （Poster notice） 2017/08
19.	What treatment should be selected to obtain longer time to treatment failure (TTF) in HER2 negative metastatic breast cancer: the evaluation of the impact of agents on prognosis （Poster notice） 2017/08
20.	The current treatment of primary hyperparathyroidism in MEN1 in Japan: the analysis of data from MEN consortium of Japan. （Speech，Panelist at Symposium/Workshop (Appointed)） 2016/10/24
21.	Use of Fulvestrant for inoperable/recurrent breast cancer patients in our hospital （Speech，Panelist at Symposium/Workshop (Other)） 2016/10/22
22.	The current treatment for primary hyperparathyroidism in MEN1 in Japan: the analysis of data from MEN Consortium of Japan （Speech，General） 2016/10/01
23.	Parathyroid carcinoma in MEN1:report of a case （Poster notice，General） 2016/09/30
24.	Long-term prognosis of advanced papillary thyroid carcinoma with extra-thyroidal extension: Role of "shaving-off" resection （Speech，General） 2016/04/08
25.	Correlation of immediate reconstruction with clinical outcome to locally advanced breast cancer （Poster notice，General） 2015/12/20
26.	Predicting no metastases to axillary lymph nodes beyond positive sentinel nodes in patients with breast cancer: a simple rule （Poster notice，General） 2015/12/20
27.	Factors associated with long-term biochemical cure after surgical treatment of hereditary medullary thyroid carcinoma(HMTC) （Poster notice，General） 2015/10/20
28.	Clinical outocomes of individualized approarch of parathyroidectomy to patients with primary hyperparathyroidism(PHPT) in multiple endocrine neoplasia type 1(MEN1):the experienced at a single institution （Poster notice，General） 2014/09/26
29.	Cinacalcet has a limited effect in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: a case report （Poster notice，General） 2013/09/21
Display 5 items
Display all(29)

■ Qualifications & licenses

1.

2021/05/01

Board-certified Senior Doctor Member of the Japanese Society for Hereditary Tumors

■ Research areas

General surgery and pediatric surgery

■ Awards & honors

1.

2007/08

International Association of Endocrine Surgery IAES　poster　prize

■ Education

1.

Faculty of Medicine, Tokyo Women's Medical University, Graduated

■ Academic & professional experience

1.	2022/02	Tokyo　Women's　Medical University Endocrine　Surgery Associate Professor
2.	2000/04～2007/03	Research Assistant